TNFR1 membrane reorganization promotes distinct modes of TNFα signaling.
HeLa Cells
Humans
MAP Kinase Kinase 4
/ genetics
MAP Kinase Kinase Kinase 1
/ genetics
MAP Kinase Signaling System
NF-kappa B
/ genetics
Receptors, Tumor Necrosis Factor, Type I
/ genetics
Transcription Factor AP-1
/ genetics
Tumor Necrosis Factor-alpha
/ genetics
p38 Mitogen-Activated Protein Kinases
/ genetics
Journal
Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400
Informations de publication
Date de publication:
30 07 2019
30 07 2019
Historique:
entrez:
1
8
2019
pubmed:
1
8
2019
medline:
15
8
2020
Statut:
epublish
Résumé
Signaling by the ubiquitously expressed tumor necrosis factor receptor 1 (TNFR1) after ligand binding plays an essential role in determining whether cells exhibit survival or death. TNFR1 forms distinct signaling complexes that initiate gene expression programs downstream of the transcriptional regulators NFκB and AP-1 and promote different functional outcomes, such as inflammation, apoptosis, and necroptosis. Here, we investigated the ways in which TNFR1 was organized at the plasma membrane at the nanoscale level to elicit different signaling outcomes. We confirmed that TNFR1 forms preassembled clusters at the plasma membrane of adherent cells in the absence of ligand. After trimeric TNFα binding, TNFR1 clusters underwent a conformational change, which promoted lateral mobility, their association with the kinase MEKK1, and activation of the JNK/p38/NFκB pathway. These phenotypes required a minimum of two TNFR1-TNFα contact sites; fewer binding sites resulted in activation of NFκB but not JNK and p38. These data suggest that distinct modes of TNFR1 signaling depend on nanoscale changes in receptor organization.
Identifiants
pubmed: 31363067
pii: 12/592/eaaw2418
doi: 10.1126/scisignal.aaw2418
pii:
doi:
Substances chimiques
NF-kappa B
0
Receptors, Tumor Necrosis Factor, Type I
0
Transcription Factor AP-1
0
Tumor Necrosis Factor-alpha
0
p38 Mitogen-Activated Protein Kinases
EC 2.7.11.24
MAP Kinase Kinase Kinase 1
EC 2.7.11.25
MAP3K1 protein, human
EC 2.7.11.25
MAP Kinase Kinase 4
EC 2.7.12.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MR/K015664/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L015773/1
Pays : United Kingdom
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.